Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin

References

• Schell WA, Foulks GN, Perfect JR. Fungal infections of the eye. In: Albert D, Miller J, Azar D, Blodi B Albert and Jakobiec's Principles and Practice of Ophthalmology, 3rd. Philadelphia: WB Saunders, 2008: 159–168.
   Google Scholar
• Jones DB. Therapy of postsurgical fungal endophthalmitis. Ophthalmology 1978; 85: 357–373.
   PubMed Web of Science ®Google Scholar
• Johns KJ, O'Day DM. Pharmacological management of keratomycosis. Surv Ophthalmol 1988; 33: 178–188.
   PubMed Web of Science ®Google Scholar
• Hurtado-Sarrió M, Duch-Samper A, Cisneros-Lanuza A, . Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Arch Ophthalmol 2010; 128: 941–942.
   PubMedGoogle Scholar
• Lin RC, Sanduja N, Hariprasad SM. Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther 2008; 24: 245–248.
   PubMed Web of Science ®Google Scholar
• Garcia-Valenzuela E, Song CD. Intracorneal injection of amphotericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol 2005; 123: 1721–1723.
   PubMedGoogle Scholar
• Carrasco MA, Genesoni G. Treatment of severe fungal keratitis with subconjunctival amphotericin B. Cornea 2011; 30: 608–611.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved standard M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
   Google Scholar
• Xie L, Zhai H, Zhao J, . Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 2008; 146: 260–265.
   PubMedGoogle Scholar
• Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008; 92: 871–878.
   PubMed Web of Science ®Google Scholar
• Scott IU, Cruz-Villegas V, Flynn HW, Miller D. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 2004; 137: 583–585.
   PubMed Web of Science ®Google Scholar
• Garbino J, Ondrusova A, Baglivo E, . Successful treatment of ocular Paecilomyces lilanicus endophthalmitis with voriconazole. Scand J Infect Dis 2002; 34: 701–703.
   PubMed Web of Science ®Google Scholar
• Reis A, Sundmacher R, Tintelnot K, . Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000; 84: 932–933.
   PubMed Web of Science ®Google Scholar
• Klont RR, Eggink CA, Rijs AMM, Wesseling PE, Verweij P. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin Infect Dis 2005; 40: e110–112.
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodriguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61: 805–809.
   PubMed Web of Science ®Google Scholar
• Iqbal NJ, Boey A, Park BJ, Brandt ME. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis 2008; 62: 348–350.
   PubMed Web of Science ®Google Scholar
• Lalitha P, Shapiro BL, Srinivasan M, . Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol 2007; 125: 789–793.
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004; 137: 820–825.
   PubMed Web of Science ®Google Scholar
• Galarreta DJ, Tuft SJ, Ramsay A, Dart JK. Fungal keratitis in London: microbiological and clinical evaluation. Cornea 2007; 26: 1082–1086.
   PubMed Web of Science ®Google Scholar
• Patel SR, Hammersmith KM, Rapuano CJ, Cohen EJ. Exophiala dermatitidis keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2006; 32: 681–684.
   PubMedGoogle Scholar
• Benaoudia F, Assouline M, Pouliquen Y, Bouvet A, Guého E. Exophiala (Wangiella) dermatitidis keratitis after keratoplasty. Med Mycol 1999; 37: 53–56.
   Web of Science ®Google Scholar
• Hernández-Prats C, LIinares-Tello F, Burgos San José A, Selva-Otaolaurruchi J, Ordovás-Baines JP. Voriconazole in fungal keratitis caused by Scedosporium apiospermum. Ann Pharmacother 2004; 38: 414–417.
   Google Scholar
• Saracli MA, Erdem U, Gonlum A, Yildiran ST. Scedosporium apiospermum keratitis treated with itraconazole. Med Mycol 2003; 41: 111–114.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211–4213.
   PubMed Web of Science ®Google Scholar
• Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A method. Mycoses 2005; 48: 246–250.
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Castelli MV, Cuesta I, . Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob Agents Chemother 2009; 53: 1686–1689.
   PubMed Web of Science ®Google Scholar
• Alastruey-Izquierdo A, Castelli MV, Cuesta I, . In vitro activity of antifungals against zygomycetes. Clin Microbiol Infect 2009; 15: 71–76.
   PubMed Web of Science ®Google Scholar